Linkedin
Facebook
Twitter
Youtube

22 Jul Arbor Biotechnologies

Posted at 18:05h in by

Devyn Smith, Ph.D., CEO

Oct. 14 | 10:00am | BlueRock Therapeutics Ballroom

Cambridge, MA
(Private)

In-person Presentation
Arbor Biotechnologies operates in the healthcare industry focusing on biotechnology business. The company was founded in 2016 and is headquartered in Cambridge, Massachusetts. We are discovering, developing, and making the next generation of genetic medicines available to all patients. We are disrupting the field through our differentiated genetic editing and delivery capabilities, developed using a proprietary discovery engine. We own a unique portfolio of CRISPR-based genetic modifiers that can be tailored to correct the underlying pathology of each genetic disease. Our pipeline of genetic medicines will be focused on bringing cures to all patients with genetic disease.
www.arbor.bio.com



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 11-13, 2022
Carlsbad, CA

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions